APA Alıntı

Xia, M., Li, X., Diao, Y., Du, B., & Li, Y. (2020). Targeted inhibition of glutamine metabolism enhances the antitumor effect of selumetinib in KRAS-mutant NSCLC. Transl Oncol.

Chicago Stili Alıntı

Xia, Meng, Xuena Li, Yao Diao, Bulin Du, ve Yaming Li. "Targeted Inhibition of Glutamine Metabolism Enhances the Antitumor Effect of Selumetinib in KRAS-mutant NSCLC." Transl Oncol 2020.

MLA Alıntı

Xia, Meng, et al. "Targeted Inhibition of Glutamine Metabolism Enhances the Antitumor Effect of Selumetinib in KRAS-mutant NSCLC." Transl Oncol 2020.